Skip to main content
. 2022 Nov 4;114(1):211–220. doi: 10.1111/cas.15574

FIGURE 2.

FIGURE 2

Plasma concentration of ONO‐4578 at day 28 of cycle 1 in patients with solid tumors treated with ONO‐4578 monotherapy or in combination with nivolumab. Mean value of each patient's data is shown. Error bars represent standard deviation. In the 60 and 100 mg monotherapy cohorts and the 5 and 60 mg combination therapy cohorts, some patients' data were missing